News
News
- Novan Receives Approval to Transfer to Nasdaq Capital Market
11/04/2020 / 13:30 - GlobeNewswire - Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update
10/30/2020 / 12:30 - GlobeNewswire - Novan to Present at the Virtual Investor KOL Roundtable
10/21/2020 / 15:00 - GlobeNewswire - iBio Announces Appointment of Dr. Linda Armstrong to Board of Directors
10/14/2020 / 22:05 - GlobeNewswire - Novan’s NITRICIL™ Technology Shows In Vitro Antiviral Effect Against SARS-CoV-2 in Human Airway Infection Model
10/14/2020 / 13:00 - GlobeNewswire - Novan Strengthens Financial Leadership with Appointments of Chief Financial Officer and Seasoned Industry Executive to Board of Directors
09/24/2020 / 13:05 - GlobeNewswire - Novan Provides Pipeline and Priority Development Programs Update
09/14/2020 / 15:05 - GlobeNewswire - Novan to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
09/09/2020 / 14:05 - GlobeNewswire - Novan Announces First Patient Enrolled and Dosed in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
09/03/2020 / 15:05 - GlobeNewswire - Novan Initiates B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
08/31/2020 / 14:05 - GlobeNewswire
Real-time